Concise reviews
Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations
Read
2481
Timeswas read the article
481
Total PDF
2000
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 39 | 2 | 41 |
| 2024 November | 51 | 5 | 56 |
| 2024 October | 35 | 3 | 38 |
| 2024 September | 38 | 4 | 42 |
| 2024 August | 38 | 10 | 48 |
| 2024 July | 28 | 6 | 34 |
| 2024 June | 45 | 4 | 49 |
| 2024 May | 49 | 4 | 53 |
| 2024 April | 45 | 6 | 51 |
| 2024 March | 52 | 3 | 55 |
| 2024 February | 50 | 8 | 58 |
| 2024 January | 48 | 4 | 52 |
| 2023 December | 55 | 11 | 66 |
| 2023 November | 41 | 6 | 47 |
| 2023 October | 49 | 3 | 52 |
| 2023 September | 29 | 2 | 31 |
| 2023 August | 28 | 12 | 40 |
| 2023 July | 20 | 15 | 35 |
| 2023 June | 29 | 17 | 46 |
| 2023 May | 38 | 17 | 55 |
| 2023 April | 41 | 12 | 53 |
| 2023 March | 62 | 12 | 74 |
| 2023 February | 34 | 17 | 51 |
| 2023 January | 32 | 3 | 35 |
| 2022 December | 29 | 5 | 34 |
| 2022 November | 34 | 3 | 37 |
| 2022 October | 30 | 9 | 39 |
| 2022 September | 24 | 9 | 33 |
| 2022 August | 28 | 11 | 39 |
| 2022 July | 28 | 7 | 35 |
| 2022 June | 20 | 8 | 28 |
| 2022 May | 23 | 3 | 26 |
| 2022 April | 16 | 11 | 27 |
| 2022 March | 26 | 12 | 38 |
| 2022 February | 25 | 7 | 32 |
| 2022 January | 35 | 11 | 46 |
| 2021 December | 45 | 9 | 54 |
| 2021 November | 39 | 11 | 50 |
| 2021 October | 40 | 9 | 49 |
| 2021 September | 36 | 14 | 50 |
| 2021 August | 56 | 10 | 66 |
| 2021 July | 24 | 7 | 31 |
| 2021 June | 36 | 8 | 44 |
| 2021 May | 38 | 13 | 51 |
| 2021 April | 199 | 35 | 234 |
| 2021 March | 64 | 26 | 90 |
| 2021 February | 32 | 15 | 47 |
| 2021 January | 31 | 7 | 38 |
| 2020 December | 27 | 7 | 34 |
| 2020 November | 16 | 4 | 20 |
| 2020 October | 10 | 5 | 15 |
| 2020 September | 7 | 10 | 17 |
| 2020 August | 6 | 9 | 15 |
Show all
